FROM CLINICAL TRIALS TO REAL-WORLD EVIDENCE: SIMILAR VIROLOGIC CURE RATES AND SAFETY OUTCOMES FOLLOWING TREATMENT WITH GLECAPREVIR/PIBRENTASVIR AMONG PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION AND RECENT DRUG USE

被引：0

作者：

Aghemo, Alessio ^{[1
]}

Negro, Francesco ^{[2
]}

Gschwantler, Michael ^{[3
,4
]}

Asselah, Tarik ^{[5
]}

Bondin, Mark I. ^{[6
]}

Crown, Eric D. ^{[6
]}

Mancine, Miki ^{[6
]}

Zhang, Zhenzhen ^{[6
]}

Flisiak, Robert ^{[7
]}

Grebely, Jason ^{[8
]}

Brau, Norbert ^{[9
,10
]}

Sterling, Richard K. ^{[11
]}

机构：

[1] Humanitas Univ & Res Hosp, Milan, Italy

[2] Univ Geneva, Geneva, Switzerland

[3] Wilhelminenspital Stadt Wien, Dept Internal Med 4, Vienna, Austria

[4] Sigmund Freud Univ, Vienna, Austria

[5] Univ Paris Diderot, Hop Beaujon, AP HP,Dept Hepatol, Ctr Rech Inflammat,Viral Hepatitis,Inserm,Umr 114, Clichy, France

[6] Abbvie Inc, N Chicago, IL USA

[7] Med Univ Bialystok, Dept Infect Dis & Hepatol, Bialystok, Poland

[8] Unsw Sydney, Kirby Inst, Sydney, NSW, Australia

[9] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis & Liver Dis, New York, NY 10029 USA

[10] James J Peters Vet Affairs Med Ctr, Infect Dis Sect, Bronx, NY USA

[11] Virginia Commonwealth Univ, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Richmond, VA 23284 USA

来源：

HEPATOLOGY | 2019年 / 70卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1549

引用

页码：932A / 933A

页数：2

共 50 条

[1] Safety of Patients with Hepatitis C Virus Treated with Glecaprevir/Pibrentasvir from Clinical Trials and Real-World Cohorts
Forns, Xavier
Feld, Jordan J.
Dylla, Douglas E.
Pol, Stanislas
Chayama, Kazuaki
Hou, Jinlin
Heo, Jeong
Lampertico, Pietro
Brown, Ashley
Bondin, Mark
Tatsch, Fernando
Burroughs, Margaret
Marcinak, John
Zhang, Zhenzhen
Emmett, Amanda
Gordon, Stuart C.
Jacobson, Ira M.
ADVANCES IN THERAPY, 2021, 38 (06) : 3409 - 3426
[2] Safety of Patients with Hepatitis C Virus Treated with Glecaprevir/Pibrentasvir from Clinical Trials and Real-World Cohorts
Xavier Forns
Jordan J. Feld
Douglas E. Dylla
Stanislas Pol
Kazuaki Chayama
Jinlin Hou
Jeong Heo
Pietro Lampertico
Ashley Brown
Mark Bondin
Fernando Tatsch
Margaret Burroughs
John Marcinak
Zhenzhen Zhang
Amanda Emmett
Stuart C. Gordon
Ira M. Jacobson
Advances in Therapy, 2021, 38 : 3409 - 3426
[3] Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: Real-world effectiveness and safety in Taiwan
Liu, Chen-Hua
Liu, Chun-Jen
Hung, Chien-Ching
Hsieh, Szu-Min
Su, Tung-Hung
Sun, Hsin-Yun
Tseng, Tai-Chung
Chen, Pei-Jer
Chen, Ding-Shinn
Kao, Jia-Horng
LIVER INTERNATIONAL, 2020, 40 (04) : 758 - 768
[4] Real-world effectiveness and safety of glecaprevir/pibrentasvir therapy in patients with chronic hepatitis C virus infection in Switzerland
Mullhaupt, Beat
Semela, David
Ruckstuhl, Lisa
Magenta, Lorenzo
Clerc, Olivier
Torgler, Ralph
Negro, Francesco
Semmo, Nasser
SWISS MEDICAL WEEKLY, 2021, 151
[5] Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir
Alessio Aghemo
Yves Horsmans
Stefan Bourgeois
Mark Bondin
Michael Gschwantler
Harald Hofer
Nasser Semmo
Francesco Negro
Zhenzhen Zhang
John Marcinak
Ella Veitsman
Rawi Hazzan
Konstantinos Mimidis
Ioannis Goulis
Nuno Marques
Robert Flisiak
Wlodzimierz Mazur
Carlos Roncero
Fiona Marra
Georges Philippe Pageaux
Tarik Asselah
Pietro Lampertico
Infectious Diseases and Therapy, 2021, 10 : 2203 - 2222
[6] Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C
D'Ambrosio, Roberta
Pasulo, Luisa
Puoti, Massimo
Vinci, Maria
Schiavini, Monica
Lazzaroni, Sergio
Soria, Alessandro
Gatti, Federico
Menzaghi, Barbara
Aghemo, Alessio
Capelli, Francesca
Rumi, Maria Grazia
Morini, Lorenzo
Giorgini, Alessia
Pigozzi, Marie Graciella
Rossini, Angelo
Maggiolo, Franco
Pan, Angelo
Memoli, Massimo
Spinelli, Ombretta
Del Poggio, Paolo
Saladino, Valeria
Spinetti, Angiola
De Bona, Anna
Capretti, Andrea
Uberti-Foppa, Caterina
Bonfanti, Paolo
Terreni, Natalia
Menozzi, Fernanda
Colombo, Alberto Eraldo
Giglio, Omar
Centenaro, Riccardo
Borghi, Marta
Baiguera, Chiara
Picciotto, Viviana
Landonio, Simona
Gori, Andrea
Magnani, Carlo
Noventa, Franco
Paolucci, Stefania
Lampertico, Pietro
Fagiuoli, Stefano
JOURNAL OF HEPATOLOGY, 2019, 70 (03) : 379 - 387
[7] Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir
Aghemo, Alessio
Horsmans, Yves
Bourgeois, Stefan
Bondin, Mark
Gschwantler, Michael
Hofer, Harald
Semmo, Nasser
Negro, Francesco
Zhang, Zhenzhen
Marcinak, John
Veitsman, Ella
Hazzan, Rawi
Mimidis, Konstantinos
Goulis, Ioannis
Marques, Nuno
Flisiak, Robert
Mazur, Wlodzimierz
Roncero, Carlos
Marra, Fiona
Pageaux, Georges Philippe
Asselah, Tarik
Lampertico, Pietro
INFECTIOUS DISEASES AND THERAPY, 2021, 10 (04) : 2203 - 2222
[8] Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C
Hsu, Shih-Jer
Chiu, Min-Chin
Fang, Yu-Jen
Yang, Tsung-Hua
Yu, Jian-Jyun
Chen, Chieh-Chang
Kuo, Chia-Chi
Lee, Ji-Yuh
Chen, Chien-Hung
Chen, Ding-Shinn
Kao, Jia-Horng
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2019, 118 (08) : 1187 - 1192
[9] Glecaprevir/Pibrentasvir for the Treatment of Patients with Chronic Hepatitis C Virus Infection: Updated Real-World Data from the German Hepatitis C-Registry
Wiegand, Johannes
Naumann, Uwe
Stoehr, Albrecht
Sick, Christoph
John, Christine
Teuber, Gerlinde
Schiffelholz, Willibold, Sr.
Mauss, Stefan
Lohmann, Kristina
Koenig, Bettina
Pangerl, Andreas
Simon, Karl-Georg
HEPATOLOGY, 2018, 68 : 364A - 364A
[10] Real-world data on safety and effectiveness of glecaprevir/pibrentasvir for the treatment of patients with chronic hepatitis C virus infection: updated data from the German Hepatitis C-Registry
Cornberg, M.
Naumann, U.
Stoehr, A.
Sick, C.
Teuber, G.
Schiffelholz, W.
Mauss, S.
Lohmann, K.
Kleine, H.
Pangerl, A.
Mueller, T.
JOURNAL OF VIRAL HEPATITIS, 2018, 25 : 197 - 198

← 1 2 3 4 5 →